These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12432572

  • 1. Induction of oral tolerance in experimental antiphospholipid syndrome by feeding with polyclonal immunoglobulins.
    Krause I, Blank M, Sherer Y, Gilburd B, Kvapil F, Shoenfeld Y.
    Eur J Immunol; 2002 Dec; 32(12):3414-24. PubMed ID: 12432572
    [Abstract] [Full Text] [Related]

  • 2. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
    Blank M, George J, Barak V, Tincani A, Koike T, Shoenfeld Y.
    J Immunol; 1998 Nov 15; 161(10):5303-12. PubMed ID: 9820503
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
    Blank M, Anafi L, Zandman-Goddard G, Krause I, Goldman S, Shalev E, Cervera R, Font J, Fridkin M, Thiesen HJ, Shoenfeld Y.
    Int Immunol; 2007 Jul 15; 19(7):857-65. PubMed ID: 17576752
    [Abstract] [Full Text] [Related]

  • 4. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY.
    Arthritis Res Ther; 2004 Jul 15; 6(3):R213-9. PubMed ID: 15142267
    [Abstract] [Full Text] [Related]

  • 5. Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.
    George J, Yacov N, Breitbart E, Bangio L, Shaish A, Gilburd B, Shoenfeld Y, Harats D.
    Cardiovasc Res; 2004 Jun 01; 62(3):603-9. PubMed ID: 15158153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY, Park KS, Cho ML, Kang JW, Cho YG, Hwang SY, Park MJ, Yoon CH, Min JK, Lee SH, Park SH, Kim HY.
    Arthritis Rheum; 2006 Mar 01; 54(3):887-98. PubMed ID: 16508971
    [Abstract] [Full Text] [Related]

  • 9. Induction of low dose oral tolerance in IL-10 deficient mice with experimental autoimmune encephalomyelitis.
    Gonnella PA, Waldner HP, Kodali D, Weiner HL.
    J Autoimmun; 2004 Nov 01; 23(3):193-200. PubMed ID: 15501390
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance.
    Barbey C, Donatelli-Dufour N, Batard P, Corradin G, Spertini F.
    Clin Exp Allergy; 2004 Apr 01; 34(4):654-62. PubMed ID: 15080822
    [Abstract] [Full Text] [Related]

  • 12. Kinetic analysis of oral tolerance: memory lymphocytes are refractory to oral tolerance.
    Chung Y, Chang SY, Kang CY.
    J Immunol; 1999 Oct 01; 163(7):3692-8. PubMed ID: 10490964
    [Abstract] [Full Text] [Related]

  • 13. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.
    George Chandy A, Hultkrantz S, Raghavan S, Czerkinsky C, Lebens M, Telemo E, Holmgren J.
    Immunology; 2006 Jul 01; 118(3):311-20. PubMed ID: 16827892
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA, Flye MW.
    Surgery; 2005 Aug 01; 138(2):141-9. PubMed ID: 16153420
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction.
    Bleich A, Janus LM, Smoczek A, Westendorf AM, Strauch U, Mähler M, Hedrich HJ, Fichtner-Feigl S, Schölmerich J, Falk W, Hofmann C, Obermeier F.
    Gastroenterology; 2009 Jan 01; 136(1):278-87. PubMed ID: 18952084
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
    Kosiewicz MM, Alard P, Liang S, Clark SL.
    Int Immunol; 2004 May 01; 16(5):697-706. PubMed ID: 15096489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.